Information Library
Results for: Demonstrating Value - Market Access
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Podcast: Biopharma Needs Value Focused Commercial Model
Hear from the Experts — September 30, 2010
Jim Featherstone, Vice President within the Consulting group at Quintiles, talks to Outsourcing-Pharma about some of the challenges of commercializing a new drug product -
A Blueprint for Clinical / Commercial Convergence
White Paper — August 5, 2010
The development model for bio pharmaceutical companies must shift from two divergent paths to one that combines these two resources with market access strategy, information and capabilities. -
Rewarding Innovation and Value
White Paper — October 6, 2009
The impact of comparative effectiveness research on the future of drug development. -
Comparative Effectiveness Research as a Drug Development Tool
Hear from the Experts — September 1, 2009
A Q&A with John Doyle sheds light on the complex issue of comparative effectiveness research, and its strategic importance in successful and efficient biopharmaceutical development.
Page 1 of 1 (4 results)
